PMID: 6103441May 24, 1980Paper

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility

Lancet
J R BatchelorG I Russell

Abstract

26 patients with systemic lupus erythematosus (SLE) induced by treatment with the antihypertensive drug hydralazine were investigated to determine if predisposition to the toxic effect was associated with an HLA-DR antigen. 25 of the 26 patients were slow acetylators. The group was compared with three others (1) 113 healthy subjects, untested for acetylator phenotype, (2) 16 slow-acetylator hypertensive patients treated with hydralazine for more than a year without developing SLE, and (3) 20 patients with idiopathic SLE. The frequency of HLA-DR4 (73%) was significantly higher in the group with hydralazine-induced SLE than in the other groups (respectively 33%, 25%, and 25%). The ratio of women to men affected was 4:1. If the slow acetylators treated with hydralazine were analysed as one group, it was observed that all women with DR4 developed hydralazine-induced SLE; the only men to do so were those with DR2 who were receiving 200 mg hydralazine per day. These observations have led us to suggest guide lines for hydralazine therapy and point to a striking association between an HLA-DR antigen and an adverse reaction to a therapeutic agent. It was also noted that the distribution of DR antigens in the hydralazine-SLE patients was...Continue Reading

References

Sep 1, 1978·The Journal of Experimental Medicine·C E Hayes, F H Bach
Apr 20, 1978·The New England Journal of Medicine·P Stastny
Sep 7, 1978·The New England Journal of Medicine·J L ReinertsenD L Mann
May 1, 1977·Clinical Pharmacokinetics·P K LundeV Hansteen
Dec 20, 1979·The New England Journal of Medicine·A CeladaM Jeannet
Feb 20, 1954·Journal of the American Medical Association·H M PERRY, H A SCHROEDER

❮ Previous
Next ❯

Citations

Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Rebecca PavlosElizabeth Phillips
Sep 1, 1994·Journal of Clinical Pharmacology·D G May
Jan 1, 1986·Rheumatology International·G S AlarcónW J Koopman
Feb 1, 1990·Biochemical Genetics·L C EzeA U Ogan
Jan 1, 1984·European Journal of Clinical Pharmacology·J A TimbrellR Mansilla-Tinoco
Jun 1, 1993·Cardiovascular Drugs and Therapy·L Arcavi, N L Benowitz
Jan 1, 1986·Springer Seminars in Immunopathology·M B Stevens
Jan 25, 2003·Current Allergy and Asthma Reports·Dean J NaisbittB Kevin Park
Jan 1, 1992·Molecular Aspects of Medicine·M Baines, A Ebringer
Jan 1, 1989·Pharmacology & Therapeutics·D A Evans
Jun 1, 1981·Journal of Affective Disorders·L J WhalleyK C Watson
Aug 1, 1986·International Journal of Cardiology·A ZezulkaL M Shapiro
Dec 31, 1998·The American Journal of Medicine·O ElkayamD Caspi
Feb 25, 1984·Lancet·J B WarrenC T Turner
Apr 21, 1998·Human Immunology·L E AdamsE V Hess
Jun 27, 1998·Clinics in Dermatology·K D Pramatarov
Feb 1, 2011·Cellular & Molecular Immunology·Francesca MedaCarlo Selmi
Oct 18, 1984·The New England Journal of Medicine·Y Shoenfeld, R S Schwartz
Mar 11, 2005·The New England Journal of Medicine·Andrew E Moran, Richard S Cooper
Jan 15, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·David H AdamsHartmut Jaeschke
May 7, 2010·Current Opinion in Rheumatology·Dipak R Patel, Bruce C Richardson
Nov 1, 1992·British Journal of Clinical Pharmacology·B K ParkN R Kitteringham
Jun 1, 1990·The British Journal of Dermatology·J KnopH Grosse-Wilde
Mar 1, 1992·Clinical and Experimental Dermatology·C BlackK Welsh
Oct 1, 1990·International Journal of Dermatology·N K TsankovE V Obreshkova
Aug 1, 1995·The Australasian Journal of Dermatology·S M Breathnach
Oct 1, 1983·Pediatric Dermatology·N H Shear, S P Spielberg
Jun 1, 1996·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·A Arnaiz-VillenaJ L Vicario

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.